image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
c04d22655e345df8821e0568fe9546cd8e370b5d9c4c030bd5ef05c03682cec6.png | simple | <table><tr><td>Barriers to delivery</td><td>Quotes</td></tr><tr><td>Time</td><td><i>“Did not have time to complete all activities”.</i> (Teacher, school 20, self-evaluation data)</td></tr><tr><td>Environment</td><td><i>“It was weather more than anything you know. The game where we had to have the cone... |
69de3cdff912bbb3213b7132d10b181890735dc7a04fd948739331c9d9e39fbb.png | complex | <table><tr><td colspan="4">Total = 939 individuals</td></tr><tr><td>Parameter</td><td>NGT <i>n</i> = 473 (50.4%)</td><td>Pre-DM <i>n</i> = 250 (26.6%)</td><td>T2DM <i>n</i> = 216 (23%)</td></tr><tr><td>Age (years)</td><td> </td><td> </td><td> </td></tr><tr><td> Mean ± SD</td><td>48.5 ± 12.9</td><td>52 ± ... |
b846c825c5035601859957b0bad526498bed21698680b44b0855e3e69469a345.png | simple | <table><tr><td>Variable</td><td>Placebo Frequency (%)</td><td>Caffeine Frequency (%)</td></tr><tr><td>Nervousness</td><td>1 (4.8)</td><td>5 (23.8)</td></tr><tr><td> AA homozygotes</td><td>1 (20)</td><td>0 (0)</td></tr><tr><td> C allele carriers</td><td>0 (0)</td><td>5 (31.3)</td></tr><tr><td>Insomnia</td><td>3 (14.3)</... |
03bd96e1d1a07f972a8bfa3c2371aa9e55ebc1a72f25d214fff3a3834f4ade03.png | simple | <table><tr><td>S.no.</td><td>Lab. no.</td><td>Binary code</td><td>Octal code</td><td>ST</td><td>Lineage</td></tr><tr><td>1</td><td>LN 8</td><td>□□□■■■□■■■■■■■■■■■■■■■■■■&... |
e1a0a7b3a75f725d8024a435bcd38a565c088f5c9430518aa7bab3e7cfafa785.png | simple | <table><tr><td>Variable</td><td>Dominant</td><td>Non-dominant</td><td>Diff</td><td>AI%</td><td>p value</td><td>Effect size</td></tr><tr><td>Ankle angles (deg)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>DorsiF (+)/PlantF(−)</td><td>11.1 ± 7.6</td><td>12.0 ± 7.3</td><td>0.9</td... |
f866d059ff9e2e9e43958b73dda26d048f9f3618b5fc1652ccde35e08f4156af.png | complex | <table><tr><td colspan="4">Escalation phase</td><td colspan="3">Extension phase</td></tr><tr><td>Dose level(mg/kg)</td><td>No. of patients</td><td>DLT</td><td>Patients with grade 3–4 lirilumab-related adverse events</td><td>Dose level(mg/kg)</td><td>No. of patients</td><td>Patients with grade 3–4 lirilumab-... |
10a117046b4327a28e1880d1d547175d136114b5f1b19b1be6158055a90fe48b.png | simple | <table><tr><td>Protein</td><td>Activator</td><td>Repressor</td></tr><tr><td>AP1</td><td>[AP1 SEP]</td><td>[AG AG]</td></tr><tr><td>AP3</td><td>[AP1 SEP], [AG SEP], [AP3 PI]</td><td></td></tr><tr><td>PI</td><td>[AP1 SEP], [AG SEP], [AP3 PI]</td><td></td></tr><tr><td>AG</td><td>[AG SEP], [AG AG]</td><td>[AP1 AP1]</td></t... |
f445175256256a0eb673cc8a54afc8f7f3025f92b9943d5857cc107ae8c7ad0e.png | simple | <table><tr><td>Solvent</td><td>Δ<i>f</i></td><td>Ex</td><td>Em<sub>max</sub></td><td>(vA-vF)*(10<sup>-3</sup>) cm<sup>-1</sup></td><td>Symbols and labels in Figure 3</td></tr><tr><td>AB</td><td>0.32</td><td>275</td><td>388</td><td>10.6</td><td> AB</td></tr><tr><td>AB</td><td>0.32</td><td>280</td><td>389 <sup>a</su... |
b6f7460913ddd51609a6828a52ae7a2e20d89ee91b96056adefce7ca51bf4bd5.png | complex | <table><tr><td rowspan="2">Blend composition</td><td colspan="3">Electrospinning parameters</td></tr><tr><td>Voltage, kV</td><td>Solution supply rate, ml/h</td><td>Distance between spinneret and collector, cm</td></tr><tr><td>3% Tec-80A + 5% GL</td><td>19.0</td><td>1.3</td><td>20</td></tr><tr><td>3% Tec-80A + 10% GL</t... |
2230919cc25a176bc176c47739a007797866abb3fd4655c2cd5271eb1b7e1dfb.png | complex | <table><tr><td> </td><td colspan="4">UEBMI</td><td colspan="4">NCMS</td></tr><tr><td> </td><td>Expenditure (¥)</td><td>Out-of-pocket payment (%)</td><td>Hospital stay (day)</td><td>Expenditure per day (¥)</td><td>Expenditure (¥)</td><td>Out-of-pocket payment (%)</td><td>Hospital stay (day)</td><td>Expend... |
a0fed634a847eb48e3f721386b2f7ee042d21fe7a86710b48141f3f57195eaef.png | simple | <table><tr><td>Gene</td><td>Accession number</td><td>Probe sequence (5′-> 3′)</td></tr><tr><td>Cd68</td><td>NM_001031638</td><td>ATCCTCATTTCTTCAGCATGCAATTGACTCAACAGAGTTATCTCCCTTCTCTGTCTTTAAA</td></tr><tr><td>RT1-B<sup>b</sup></td><td>NM_001004084</td><td>CAGCTGTGACAGTTGTGAAATACCCTAGCTTCTGATAACAGAATGAGTTA... |
eff8e68bafd953e895ee9285333302ab040168cd8521cd02fff737e0fdd1ef3a.png | complex | <table><tr><td rowspan="2">Variables</td><td rowspan="2">Number (n)</td><td colspan="2">R-Ras expression</td><td rowspan="2"><i>p</i>-value</td></tr><tr><td>Positive (n=83)</td><td>Negative (n=109)</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td>0.389</td></tr><tr><td> Male</td><td>112</td><td>45</td><td>67<... |
e2e7191040fb4419f3fae2679d3706056963bb4f8438277e1bd514f159baba36.png | simple | <table><tr><td>Clinical parameters</td><td>Correlation coefficient</td><td>P-value (2-tailed)</td></tr><tr><td>CEA</td><td>−0.023</td><td>0.885</td></tr><tr><td>CA125</td><td>−0.025</td><td>0.883</td></tr><tr><td>CA153</td><td>0.007</td><td>0.966</td></tr><tr><td>CA199</td><td>−0.048</td><td>0.761</td... |
2972820ffda8da206ef95f5b44b7f9e02f98d5a5734c21c5638a2dc5571a44d2.png | complex | <table><tr><td></td><td></td><td colspan="3">Women</td><td colspan="3">Men</td></tr><tr><td>Increased use</td><td></td><td>OR</td><td colspan="2">95% CI</td><td>OR</td><td colspan="2">95% CI</td></tr><tr><td>Any substance</td><td>PTSD symptoms</td><td>*1.143</td><td>1.112</td><td>1.174</td><td>*1.108</td><td>1.088</td>... |
bc72c638101c3f9e34b20f8676f73fdf4a6c69803c5bcf32614a9b9d09e589a1.png | complex | <table><tr><td></td><td colspan="2">3 weeks</td><td colspan="2">5 weeks</td></tr><tr><td></td><td>HF</td><td>HFPL</td><td>HF</td><td>HFPL</td></tr><tr><td></td><td>(n = 10)</td><td>(n = 8)</td><td>(n = 9)</td><td>(n = 10)</td></tr><tr><td>Initial body wt (g)</td><td>17.6 ± 0.5</td><td>17.1 ± 0.9</td><td>18.0 ... |
c2c8769a0dda7e26240b01ae46f5563e1206b91130d08adecf6f830aa27b5fcb.png | complex | <table><tr><td rowspan="2">Model 2</td><td>B</td><td>SE</td><td>HR</td><td colspan="2">95% CI</td><td rowspan="2">p</td></tr><tr><td></td><td></td><td></td><td>Inferior</td><td>Superior</td></tr><tr><td>Male gender</td><td>.68</td><td>.23</td><td>1.97</td><td>1.27</td><td>3.08</td><td>0.003</td></tr><tr><td>Age</td><td... |
811722f84b8d9ff3acf3bdbab19c27ad19c1612dba2dc49d9ec3bb6425560193.png | complex | <table><tr><td>Threshold on Wells scale = 2</td><td>Thrombosis</td><td>Without Thrombosis</td></tr><tr><td>Number of points on the Wells scale: >2</td><td>40</td><td>60</td></tr><tr><td>Number of points on the Wells scale: ≤2</td><td>20</td><td>928</td></tr><tr><td>Sensitivity: 66.66%</td><td colspan="2">Posit... |
07e23531990c097fa14476b97e30446c4cf991e745fbf918f260e7c70b9c8af8.png | complex | <table><tr><td></td><td colspan="5">Probabilities</td></tr><tr><td>Variable</td><td><i>No RX</i></td><td><i>rFVIIa (40 mcg)</i></td><td><i>rFVIIa (80 mcg)</i></td><td>Utilities</td><td><i>Range</i></td></tr><tr><td>Mild post-ICH deficit (mRS 0–1)</td><td>0. 08</td><td>0. 17</td><td>0. 21</td><td>0. 81</td><td>0. ... |
9d518739fc19da9cbe17f839963dafa2663209a7ed2db57b203b53d8807e7b3b.png | simple | <table><tr><td> </td><td>1.5T SSFP 1.2x1.2x6mm<sup>3</sup></td><td>7T FGRE 1.2x1.2x6mm<sup>3</sup></td><td>7T FGRE 1.3x1.3x4mm<sup>3</sup></td><td>p-value</td></tr><tr><td>RVEDV [ml]</td><td> </td><td> </td><td> </td><td>0.5850</td></tr><tr><td>Median</td><td>146.2</td><td>138.6</td><td>152.1</td><td> </td></tr><tr><td... |
5f366d6745474851aa3e7d5521ea9ed0a6f95daaf03a89716e8437c3fd73ec14.png | complex | <table><tr><td>Country</td><td>Existing laws alluding to quality and patient safety</td></tr><tr><td rowspan="2">Jordan</td><td>In Jordanian law, the Public Health Code includes articles that emphasize the state’s responsibility to provide healthcare, and the Ministry of Health’s responsibility regarding he... |
1bd418ad17484dd8463c95684fc3d68b6be599b26b44ce3a018cfd822421ba36.png | simple | <table><tr><td>Type of paper</td><td>EpidemiologyN papers (%)N citations</td><td>Eur Respir JN papers (%)N citations</td></tr><tr><td>National</td><td>17 (71)53</td><td>10 (53)18</td></tr><tr><td>(US)</td><td>9 (38)68</td><td>1 (5)6</td></tr><tr><td>(other)</td><td>8 (33)37</td><td>9 (48)18</td></tr><tr><td>Internation... |
b431b4af9df6f8163bbccbdd90615c9e26e318e2eeaa2c7df5768ff8b6e1c766.png | simple | <table><tr><td>Patients</td><td>Professionals</td></tr><tr><td>- Do you know anything about lifestyle modification (diet, exercise, etc.) in order to change your mood and depression?- All of you have taken part in a research project about modifying lifestyles. Did these recommendations that were given to you show you s... |
ce26ba3a0847e8e040f92d0a769be3317248b0c8fc4de91c97df3c28ac3d16f2.png | simple | <table><tr><td> </td><td>Risperidone</td><td>Olanzapine</td><td>Quetiapine</td><td>Ziprasidone</td><td>Aripiprazole</td><td>FGAs</td><td>No medication</td></tr><tr><td>Subjects (M/F)</td><td>47 (35/12)</td><td>13 (6/7)</td><td>44 (29/15)</td><td>2 (2/0)</td><td>1 (0/1)</td><td>5 (3/2)</td><td>39 (22/17)</td></tr><tr><t... |
6b70adadc433bce890c369b0f1a8fd5a9fc5f9c82e76c355b33f92289c6e5c5a.png | simple | <table><tr><td>Process</td><td>2<sup>o </sup>rate constant (#min<sup>-1</sup>)</td><td>Enzyme</td><td>Enz #</td><td>1<sup>o </sup>rate const (min<sup>-1</sup>)</td><td>PTM modifying rate</td><td>Rate MF</td><td>Reference</td></tr><tr><td>Synthesis (NULL → FOXO)</td><td>0.0055</td><td>E2F1</td><td>300</td><td>5.5<... |
80144ae0976f83febf9062f721907d1ce71d026636545456d15be48e15d51f4d.png | simple | <table><tr><td>Family</td><td>Species</td><td>Size of mt DNA (bp)</td><td>GenBank accession no.</td></tr><tr><td>Babesiidae</td><td><i>B. orientalis</i></td><td>5996</td><td>KF218819</td></tr><tr><td> </td><td><i>B. bovis</i></td><td>6005</td><td>EU075182</td></tr><tr><td> </td><td><i>B. bovis</i></td><td>5970</td><td>... |
5f58c0352ce89fed92ec8b336522dacc5237a95cecc940b9e20ef018bf4b8b7c.png | complex | <table><tr><td>Simulation</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td></tr><tr><td></td><td colspan="4">First 1,000 iterations (the initial peak number = 11)</td><td></td><td></td></tr><tr><td>peak birth (RGP)</td><td>0.00E-4</td><td>0.00E-4</td><td>0.00E-4</td><td>0.00E-4</td><td>0.00E-4</td><td>0.... |
ee7433d8eb80567c828b2d9880eca8a14ed7898fff33bc9760c6ecaabeef7919.png | complex | <table><tr><td></td><td colspan="2">Cause of hospitalization</td><td colspan="2">Cause of death</td></tr><tr><td>Event</td><td>N</td><td>%</td><td>N</td><td>%</td></tr><tr><td>WHO stage 2 events</td><td>1</td><td>0.65</td><td>0</td><td>0</td></tr><tr><td>WHO 3 non-specific events</td><td>10</td><td>6.45</td><td>0</td><... |
5af0831cd86822835fe3f27beb9056f48f7d5868f90c81d20811e0e426e761ca.png | complex | <table><tr><td colspan="2">Microscopy</td><td colspan="8">PCR</td></tr><tr><td></td><td>N</td><td>Pf</td><td>Pv</td><td>Pm</td><td>Po</td><td>Pf/Pv</td><td>Pf/Pm</td><td>Pv/Po</td><td>Negative</td></tr><tr><td>Pf</td><td>135</td><td>117</td><td>2</td><td>0</td><td>0</td><td>13</td><td>3</td><td>0</td><td>0</td></tr><tr... |
56ecfc0332493b2eecaa64ee7588e6157ad691e7d5e4c369c7b4ecf339f7815e.png | complex | <table><tr><td></td><td colspan="5">Patient N°</td></tr><tr><td></td><td>1.</td><td>2.</td><td>3.</td><td>4.</td><td>5.</td></tr><tr><td>Duration of tube feeding (days)</td><td>7</td><td>15</td><td>8</td><td>6</td><td>9</td></tr><tr><td>Parenteral nutritional support</td><td>none</td><td>none</td><td>12 kcal/kg/da... |
b41e5eb1b95cbbf07c4963ea6e8d0df467a6e654aeb8de65a2e6d0253b7d8b11.png | complex | <table><tr><td></td><td colspan="2">Age < 30 years (n =3148)</td><td colspan="2">Age 30-39 years (n = 9310)</td><td colspan="2">Age 40-49 years (n = 13747)</td><td colspan="2">Age ≥ 50 years (n = 3520)</td></tr><tr><td></td><td>Patients</td><td>Controls</td><td>Patients</td><td>Controls</td><td>Patients</td><t... |
f75fee465f3ccfca0c1c52085adb175ee044531ec521feeb401794482dfff01f.png | complex | <table><tr><td>Aged parental clone</td><td>Origin</td><td>Overall haematopoietic chimerism (%±s.d.)</td><td>Overall relative chimerism (%±s.d.)</td><td colspan="3">Lineage distribution of test cells in 1°transplants, iPS chimeras and 2° transplants (%±s.d.)</td><td colspan="3">Lineage distribut... |
34acd5a8e364790efb3004f0b489212a829d5dfba77a9ea26f2c4b7af38b4f05.png | complex | <table><tr><td colspan="5">Training Dataset : Protein {:Chain}{:Domain Boundaries}</td></tr><tr><td>1a6q:297–368</td><td>1lok:A</td><td>1etx:A</td><td>1nj4:A:263–355</td><td>1egw:A</td></tr><tr><td>1ako</td><td>1lqp:A</td><td>1ew4:A</td><td>1nls</td><td>1erz:A</td></tr><tr><td>1ayl:228–540</td><td>1lt... |
ed6a2741cf315841672c4d89914a1ec6eb3a31f9093b8bd6781af1d8e67e761d.png | simple | <table><tr><td>Variable name</td><td>ICC (95 % CI)<sup>a,b</sup></td></tr><tr><td>Maternal information</td><td></td></tr><tr><td> Pre-pregnancy weight</td><td>0.97 (0.96 –0.97)</td></tr><tr><td> Admission weight</td><td>0.94 (0.94 –0.95)</td></tr><tr><td> Height</td><td>0.90 (0.89 –0.92)</td></tr><tr>... |
3da0fa9ebec3160f1c3b98ebb5df97a9a4d732a74c33e063eabc9d35421e16d3.png | complex | <table><tr><td rowspan="3">Antimicrobial agent</td><td colspan="3">No. (%) of <i>H. pylori</i>-resistant strains</td></tr><tr><td>2006–2008 [13]</td><td>2009–2011</td><td rowspan="2"><i>P</i> value<sup>(1)</sup></td></tr><tr><td><i>n</i> = 115</td><td><i>n</i> = 51</td></tr><tr><td>CLA<sup>(2)</sup></td><td... |
5acc420a4ea0e1f1aced36eae65f615689b84107c31e405bcd61f1e492e56d39.png | simple | <table><tr><td>Age</td><td>0.025</td><td>0.05</td><td>0.10</td><td>0.90</td><td>0.95</td><td>0.975</td></tr><tr><td>0.4</td><td>0.2</td><td>0.3</td><td>0.5</td><td>1.8</td><td>2.0</td><td>2.2</td></tr><tr><td>1.0</td><td>0.3</td><td>0.4</td><td>0.6</td><td>1.9</td><td>2.0</td><td>2.2</td></tr><tr><td>2.0</td><td>0.4</t... |
fa540625927dd336793dde074916b3830f1e453c29db21c99e4aa57518e457fc.png | complex | <table><tr><td></td><td>Crude OR (95% CI)</td><td>Adjusted OR (95% CI)</td></tr><tr><td>Female gender (vs male)</td><td>0.9 (0.5–1.5)</td><td></td></tr><tr><td>Zhuang ethnicity (vs Han and others)</td><td>0.8 (0.5–1.5)</td><td></td></tr><tr><td colspan="3">Age group (years): ref. = < 30</td></tr><tr><td>... |
a1ccb6a34e32066f718b89c3c73e38f3187493a07c622423651e2801881d8d46.png | simple | <table><tr><td>R di Pearson p<.05</td><td>PF</td><td>PRF</td><td>BP</td><td>GHP</td><td>V</td><td>SRF</td><td>ERF</td><td>MH</td></tr><tr><td>Depression</td><td>-0.16</td><td>-0.21</td><td>-0.49*</td><td>-0.19</td><td>-0.21</td><td>-0.2</td><td>-0.14</td><td>-0.17</td></tr></table> |
e1c72ddcb53b5b58f382606efb3e73c083a09a13e1d300d144c4d34754e70167.png | simple | <table><tr><td>Date</td><td>WWTP 1</td><td>WWTP 2</td><td>WWTP 3</td><td>WWTP 4</td><td>WWTP 5</td></tr><tr><td>Jan</td><td><0.006473</td><td><0.006473</td><td><0.006473</td><td>0.43</td><td><0.006473</td></tr><tr><td>Feb</td><td><0.006473</td><td>1.74</td><td><0.006473</td><td>0.49</td><td>0.43</td><... |
db263997212c077797427451b1e14349e3ea9308abc54f1a0aa7d46d539cd786.png | complex | <table><tr><td rowspan="2">Evaluation criteria</td><td rowspan="2">Description</td><td colspan="2">Temperature and duration</td><td rowspan="2">Reference</td></tr><tr><td>Treatment</td><td>Recovery</td></tr><tr><td>Germination stage</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Vigor of germination</td><td>V... |
0cb2738b21581a875ee247ce9f4a5754c2831f555e6dfc26e68de6692df9c4e6.png | simple | <table><tr><td>Algorithm</td><td>Proposed</td><td>No Preprocessing</td><td>No Verification</td></tr><tr><td>Recognition rate</td><td>97.8%</td><td>98.1%</td><td>68.0%</td></tr><tr><td>Computation time</td><td>1018</td><td>4951</td><td>736</td></tr></table> |
647177729026b539bf2eccf3541d2e64f7af1ea46854bc0f7e187e836f211971.png | complex | <table><tr><td>Case</td><td colspan="3">Response time to deviation</td><td colspan="3">Response time to math</td></tr><tr><td></td><td>Mean</td><td>Standarddeviation</td><td>Difference(dual-single)</td><td>Mean</td><td>Standarddeviation</td><td>Difference(dual-single)</td></tr><tr><td>Case 1</td><td>0.9480</td><td>0.13... |
4a4542b06edadbed8f825cecb26dfad5220638c15bc7fe60747057d0164a214b.png | simple | <table><tr><td>Year</td><td>Tumor type</td><td>No. of cases</td><td>Culture condition</td><td>Authors</td></tr><tr><td>1999</td><td>Renal cell carcinoma Colorectal carcinoma Lymphoma</td><td>10</td><td>IFN-γ, anti-CD3, IL2 plus IL-2 transgene</td><td>Schmidt-Wolf IG et al. [33]</td></tr><tr><td>2005</td><td>Lympho... |
e33bde01c1620fa96d1a8b05bfa248499717a02c905224eba0a8b44c5122ad65.png | complex | <table><tr><td></td><td>Baseline (T0)</td><td>T1</td><td>T2</td><td>T3</td></tr><tr><td colspan="5">Mean arterial pressure (mmHg)</td></tr><tr><td> Control</td><td>91.5 ± 4.2</td><td>93 ± 4.1</td><td>94 ± 4.8</td><td>76.1 ± 2.3</td></tr><tr><td> LPS</td><td>88.7 ± 1.3</td><td>49 ± 5.1<sup>... |
adc5729930f15565c2233d9fd949a600b9a0394b8f0b4eb9af1cd016c55d74fd.png | simple | <table><tr><td>Bacterial name</td><td>Inhibitory effects<sup>*</sup></td></tr><tr><td><i>Acetic bacteria</i></td><td>-</td></tr><tr><td><i>Bacillus subtilis</i></td><td>+</td></tr><tr><td><i>E. coli</i></td><td>+++</td></tr><tr><td><i>Lactobacillus fermenti</i></td><td>-</td></tr><tr><td><i>Lactobacillus plantarum ZJ31... |
52c8e9ec9b12135354827f22dc173d5023ac6b585cf452a47eeab2da698226d2.png | complex | <table><tr><td></td><td colspan="2">Second versus first tertile</td><td colspan="2">Third versus first tertile</td></tr><tr><td>Group</td><td>β ± SE</td><td><i>p</i>-Value</td><td>β ± SE</td><td><i>p</i>-Value</td></tr><tr><td colspan="5">Full (wet weight)</td></tr><tr><td> Systolic</td><td>0.023 &#... |
c30e6b7feca8303fdfdfba5f9ddd06269c875501bc907958e2c1a056a1f71eba.png | simple | <table><tr><td>Parameters</td><td>AZT</td><td>AZT + NAR</td><td>AZT + VITE</td><td>d4T</td><td>d4T + NAR</td><td>d4T + VITE</td><td>Control</td></tr><tr><td>Final body weight (g)</td><td>307.2 ± 3.7 <sup>a</sup></td><td>316.8 ± 1.99 <sup>#</sup></td><td>303.2 ± 4.2</td><td>303.8 ± 4.1 <sup>a</sup></... |
44432383d9edae872cbca9afb6d3359ad2d174270d7a21083bbe31ff45189263.png | simple | <table><tr><td>Insertions of transgenes</td><td>Relative levels of mRNA*</td></tr><tr><td><i>P{hsp83-AtSPO11-1 </i>cDNA, <i>A5-1}</i></td><td>3.40 ± 0.40</td></tr><tr><td><i>P{hsp83-AtSPO11-2 </i>cDNA, <i>2M3-1}</i></td><td>9.22 ± 2.72</td></tr><tr><td><i>P{hsp83-OsSPO11A cDNA, 3M2-3}</i></td><td>13.88 ±... |
9387f6bdeef7ed55aadf442ee371d889ca8690c438d3a36dc076b0cfb9f77a90.png | complex | <table><tr><td>Parameter</td><td colspan="2">c-MYC Nuclear Expression</td><td colspan="2">Significance</td></tr><tr><td>ADA3 Nuclear Expression</td><td>Low No (%)</td><td>High No.(%)</td><td><i>x</i><sup>2</sup></td><td>p value</td></tr><tr><td>Low No(%)</td><td>172 (49.1)</td><td>178 (50.9)</td><td rowspan="2">23.79</... |
a221c381f7f9ff3a0379601d780dc25b8ed9388a0fe8b38700c65bb25ed4d0b2.png | simple | <table><tr><td><i>Mycobacterium smegmatis</i></td><td>Fold change</td><td>P-value</td><td>Gene name</td><td>Ortholog in <i>Mtb</i></td><td>Annotated function</td></tr><tr><td><i>MSMEG_5576</i></td><td>3.4</td><td>2.2E-02</td><td>–</td><td><i>–</i></td><td>d-mannonate oxidoreductase</td></tr><tr><td><i>MSMEG... |
c4050b0f73e87df24840dc40d60f84d425cdf75febc77febcc6a4e88c2bb3529.png | simple | <table><tr><td></td><td>Microwave biosensor [42]</td><td>Terahertz biosensor [48]</td><td>Plasmonic biosensor [55]</td></tr><tr><td>Unit size</td><td>mm</td><td>um</td><td>nm</td></tr><tr><td>Operating frequency</td><td>GHz</td><td>THz</td><td>100–800 THz</td></tr><tr><td>Application field</td><td>Detect binding ... |
9218657afc02033380e2f5b6240ae8dc4393af2c5311cb77e48ca8fc1a622a40.png | complex | <table><tr><td> </td><td colspan="3">Men (n = 371)</td><td colspan="3">Women (n = 438)</td><td colspan="3">Total (n = 809)</td></tr><tr><td> </td><td>Healthy (n = 300)</td><td>Controlled asthma (n = 59)</td><td>Uncontrolled asthma (n = 12)</td><td>Healthy (n = 306)</td><td>Controlled asthma (n = 66)</td><td>Uncontrolle... |
93d8136be125af434dd5f958f3bb76cc59fed65aa6876c7e410f8bba4cf36ceb.png | complex | <table><tr><td></td><td></td><td colspan="7">EGFR-IHC result</td><td colspan="6">EGFR-FISH result</td></tr><tr><td></td><td></td><td colspan="4">System 1</td><td colspan="3">System 4</td><td colspan="3">FISH Positive</td><td colspan="3">Amplification</td></tr><tr><td></td><td>N</td><td>L</td><td>M</td><td>H</td><td><i>... |
2861699e197bb50546e56be5c1b65f7729f273ff5dda3f70118581fec1063421.png | simple | <table><tr><td>Location</td><td>Number of HC‐markers (Table S2)</td><td>Estimated proteome size</td><td>Proteome coverage (%)</td><td>GFP localization (%)</td><td>Correct GFP localization (%)</td></tr><tr><td>CYT</td><td>2512</td><td>5587</td><td>45</td><td>15</td><td>74</td></tr><tr><td>ER</td><td>323</td><td>71... |
2cb37a04d95dfc002d6e1e2b0098c69fc422bb7d8c7c5ad5a933e761a10d51da.png | simple | <table><tr><td>Amino Acid Pattern</td><td>T1</td><td>T2</td><td>T3</td><td><i>p</i> for Trend</td></tr><tr><td>Pattern 1</td><td></td><td></td><td></td><td></td></tr><tr><td>Crude</td><td>1.00</td><td>0.97 (0.79–1.20)</td><td>1.07 (0.87–1.31)</td><td>0.61</td></tr><tr><td>Model 1</td><td>1.00</td><td>0.97 (... |
7c66980a3bc856db6e0a80fea8f199a799fadbcca87fa515698b4e10d3fbc641.png | complex | <table><tr><td></td><td colspan="4"><i>Trend percentage at T3 per T1-T2 risk state</i></td></tr><tr><td><i>T1-T2 risk state </i>(N = 180,767)</td><td><i>(0)</i></td><td><i>(1)</i></td><td><i>Comparison of order</i></td><td><i>Trend statistic (Z)</i></td></tr><tr><td>Low-Low<sup>a</sup></td><td>82.4<sup>(1)</sup></td><t... |
8fe0b30619822434160b423ad4d57b589803a2f57a6f26b7e004466a0bf3a620.png | simple | <table><tr><td>Characteristics</td><td>Scabies infected cases, <i>n</i></td><td>%</td></tr><tr><td>No. of cases</td><td>14 883 (100.0%)</td><td></td></tr><tr><td>Age (mean ± SD, years)</td><td>52.4 ± 21.0</td><td></td></tr><tr><td> 20–29</td><td>2831</td><td>19.0</td></tr><tr><td> 30–39</td><td>21... |
d852c4f75ced6026a99f5a13f3f7cf47035852a84b5bcd9663154795e2bfe331.png | simple | <table><tr><td>Variable</td><td>Total (<i>n</i> = 240) (%)</td></tr><tr><td>Teaching years </td><td> </td></tr><tr><td> (1) (1–<10)</td><td>116 (48.3%)</td></tr><tr><td> (2) (10–<20)</td><td>86 (35.8%)</td></tr><tr><td> (3) (20–<30)</td><td>38 (15.8%)</td></tr><tr><td>Classes per day </td><td... |
e830c079c9b5d23f4748448d03cf736a91ff85cf8ff7bb82360610cc56609d2c.png | simple | <table><tr><td>MIGS ID</td><td>Property</td><td>Term</td><td>Evidence code<sup>a</sup></td></tr><tr><td></td><td>Classification</td><td>Domain <i>Bacteria</i></td><td>TAS [70]</td></tr><tr><td></td><td></td><td>Phylum <i>Cyanobacteria</i></td><td>TAS [71, 72]</td></tr><tr><td></td><td></td><td>Class <i>Oscillatoriophyc... |
dbd4cc112b691a18360b1ed532f1afcabd26272af98f8954296b2f2699c28711.png | simple | <table><tr><td>Recipient vessels</td><td>Venous number (%)</td><td>Arterial number (%)</td></tr><tr><td>Retrograde IM vessel</td><td>11 (44)</td><td>16 (64)</td></tr><tr><td>Anterograde IM vessel</td><td>6 (24)</td><td>0 (0)</td></tr><tr><td>Superior pedicle continuity</td><td>5 (20)</td><td>5 (20)</td></tr><tr><td>Inf... |
17bb0d70a569095ec3c30ebdfd87a0d9a7bf14478cd1f0b3eef555e25c342c22.png | simple | <table><tr><td>Variables</td><td><i>ρ</i></td><td><i>P</i></td></tr><tr><td>Diagnosis of ANbp</td><td>0.525</td><td>0.017*</td></tr><tr><td>Age</td><td>0.345</td><td>0.136</td></tr><tr><td>Body mass index</td><td>0.168</td><td>0.479</td></tr><tr><td>Duration of illness</td><td>0.536</td><td>0.015*</td></tr><tr><td... |
f2884cf8ee545f7e88c552dd98f0f35d96a99df4e209086f8df656b6ea6eb398.png | simple | <table><tr><td>#1</td><td>Rheumatic Heart Disease or Disease, Rheumatic Heart or Diseases, Rheumatic Heart or Heart Disease, Rheumatic or Bouillaud Disease or Disease, Bouillaud</td></tr><tr><td>#2</td><td>IL 10-1082</td></tr><tr><td>#3</td><td>mutation</td></tr><tr><td>#4</td><td>polymorphism</td></tr><tr><td>#5</td><... |
fe92b5f5da5d97623eb32e802b3cc956bca2fad4280f0ad912dd20a890e19ba2.png | simple | <table><tr><td>Dosimetric Criteria</td><td>Treatment planning system</td><td>Knowledge based engineering tool</td></tr><tr><td>Spinal Cord Maximum Dose (Gy)</td><td>40 ± 2</td><td>44 ± 2</td></tr><tr><td>Esophagus Maximum Dose (Gy)</td><td>68 ± 3</td><td>75 ± 2</td></tr><tr><td>Heart V<sub>30 Gy</su... |
5573a9a772f8186aa42c3298a63a0fe56319c59a4cf12f371bfaeb4b528d1a1a.png | complex | <table><tr><td>Residential</td><td>Time</td><td>Sunlight Intensity (lux)</td><td>Temperature (°C)</td><td>Humidity (%)</td></tr><tr><td rowspan="3">Tebet Barat</td><td>08.00</td><td>44,900</td><td>28.7</td><td>79.4</td></tr><tr><td>12.00</td><td>64,700</td><td>32.7</td><td>63.4</td></tr><tr><td>16.00</td><td>24,40... |
b377444c7dd236474a14d4b08d9cce48a8cebedfc4349c2c38ae415ee2c70fc0.png | simple | <table><tr><td></td><td>FOV (mm)</td><td>Res (mm)</td><td>TR (ms)</td><td>TE (ms)</td><td>FA (deg)</td><td>BW (Hz/px)</td><td>Scan time (s)</td><td># views</td></tr><tr><td>UTE T1</td><td>160×160×160</td><td>1.0×1.0×1.0</td><td>11</td><td>0.05</td><td>8, 36</td><td>1008</td><td>167</td><td>15000</td... |
48fbf25cbc0443c4747fb1db7b3952f42b239c659452d432451f256382f6164f.png | simple | <table><tr><td>Marker name</td><td>Position (galGal3 assembly)</td><td>Upper primer</td><td>Lower primer</td><td>PCR annealing T°</td></tr><tr><td>SEQALL0348</td><td><underline>chr1:135392697-135392876</underline></td><td>GCTCAGCACCTCCTCCTC</td><td>AGAAAGCAGCCTCACAAAGC</td><td>55°C</td></tr><tr><td>SEQALL0349... |
1d7afcc6cda46f28cb657e33831c2c4925617d1ac31b238cb915009a7f3f2921.png | simple | <table><tr><td>Characteristics</td><td>n (%)</td><td>Mean ± S.D</td></tr><tr><td><underline>Socio-demography</underline></td><td></td><td></td></tr><tr><td>Age (years)</td><td></td><td>49.7 ± 14.1</td></tr><tr><td>24 – 34</td><td>14 (15.6)</td><td></td></tr><tr><td>35 – 49</td><td>30 (33.3)</td><t... |
ba00c957b032f345a138111d2a191246886a4501f8c26db86de36697e2077d28.png | simple | <table><tr><td>Glycerol Content (%)</td><td>Elastic Modulus (MPa)</td><td>Elongation at Break (%)</td><td>Tensile Strength (MPa)</td></tr><tr><td>0</td><td>0.64 ±0.09</td><td>53.58 ±8.69</td><td>0.21 ±0.05</td></tr><tr><td>10</td><td>4.08 ±0.53</td><td>130.37 ±29.67</td><td>0.73 ±0.09</td>... |
2d98bcaf57aec4a11f26b138e9a09c80a94393f4e33d8084a276cd45c9a82cb7.png | simple | <table><tr><td>Variable</td><td>GlavonoidTM Pre(n = 11)</td><td>GlavonoidTM Post(n = 11)</td><td>PlaceboPre(n = 11)</td><td>PlaceboPost(n = 11)</td></tr><tr><td>Insulin (μU·mL<sup>-1</sup>)</td><td>7.9 ± 1.3</td><td>9.2 ± 1.5</td><td>9.1 ± 0.5</td><td>8.4 ± 1.2</td></tr><tr><td>HOMA-IR</td... |
2b5c80c04f12a63b8f72d1860b5748bc1f3194b28fa7032e2b66eba6db732224.png | complex | <table><tr><td rowspan="3">HCV seropositivity status groups(number of subjects)</td><td rowspan="3">group AHCV Ab(−)<i>n</i> = 968</td><td rowspan="3">group B and CHCV Ab(+)<i>n</i> = 109</td><td>group B</td><td>group C</td><td rowspan="3">All subjects<i>n</i> = 1077</td></tr><tr><td>HCV Ab(+) Ag(−)<i>n</i>... |
faa0a0bde10fede158d5c8678dbddc455c79c200882f89af1360a2575ce30832.png | complex | <table><tr><td></td><td colspan="4">Off-treatment analysis</td><td></td><td></td></tr><tr><td></td><td colspan="2">Included</td><td colspan="2">Excluded</td><td colspan="2">FREEDOM25</td></tr><tr><td></td><td>Placebo (<i>N</i>1 = 470)</td><td>Denosumab (<i>N</i>1 = 327)</td><td>Placebo (<i>N</i>2 = 520)</td><td>Denosum... |
748a88d641cfabea340e2e62f5ab6cca6829e8931319ad198d0807c2d21736db.png | simple | <table><tr><td></td><td>Apoptotic cells sub-G1</td><td>G1</td><td>S</td><td>G2/M</td></tr><tr><td>FemX</td><td></td><td></td><td></td><td></td></tr><tr><td>Control</td><td>0.30</td><td>58.19</td><td>15.42</td><td>22.87</td></tr><tr><td><i>T. candida</i></td><td>5.34</td><td>47.64</td><td>15.09</td><td>31.93</td></tr><t... |
2cf3fb31fa5295ed7a6698722d04fd7e4446dd0842cedc9a5fffeb5595a6edd2.png | simple | <table><tr><td>Characteristic</td><td>Total cohort(<i>n</i> = 63)</td><td>Yoga group(<i>n</i> = 29)</td><td>Control group(<i>n</i> = 34)</td></tr><tr><td>Age (y)</td><td>37.2 ± 10.8</td><td>38.2 ± 10.1</td><td>36.3 ± 11.4</td></tr><tr><td>Women (n; %)</td><td>50; 79%</td><td>23; 79%</td><td>27; 79%</td><... |
5bfdd8bdc42284d5f71a821a0f1b5770adcf0e068da4f4321f57757c41f5f3e5.png | simple | <table><tr><td>Source</td><td>d.f.</td><td>MS</td><td>F</td><td>P</td></tr><tr><td>Line</td><td>3</td><td>0.006</td><td>2.119</td><td>0.269</td></tr><tr><td>Cactus</td><td>1</td><td>0.004</td><td>1.145</td><td>0.365</td></tr><tr><td>Line × Cactus</td><td>3</td><td>0.003</td><td>2.623</td><td>0.067</td></tr><tr><td... |
0d05e5dee333c428d251b430202df482b6e23a10809351bfa3a40d2d4edc7c70.png | complex | <table><tr><td>Characteristic</td><td>All Countries</td><td>South Africa</td><td>Tanzania</td><td>Zimbabwe</td></tr><tr><td>Qualitative FGDs (parents)</td><td>N = 192</td><td>n = 59</td><td>n = 60</td><td>n = 73</td></tr><tr><td> Mean age, y (SD)</td><td>39.9 (11.5)</td><td>40.5 (10.1)</td><td>36.1 (10.1)</td><td>42.5 ... |
0bb0dddbb2e682352c75a3cd4acbdc72a35465479d6f78d8225ce60daf81c9f7.png | simple | <table><tr><td>Patients code</td><td>Sex</td><td>Infection status</td><td>CD4</td><td>HIV load</td><td>HCV load</td></tr><tr><td>H1*</td><td>F</td><td>HIV</td><td>288</td><td>140222</td><td>NUL</td></tr><tr><td>H2</td><td>M</td><td>HIV</td><td>56</td><td>373429</td><td>NUL</td></tr><tr><td>H3</td><td>F</td><td>HIV</td>... |
36a8739e480639272a058b820be132321f00d0f690c7a0c6d00b2bb1429b47ee.png | complex | <table><tr><td></td><td colspan="3">Percentage cilia</td><td colspan="3">Length, μm</td></tr><tr><td></td><td>Cycling</td><td>Assemb</td><td>Disassemb</td><td>Cycling</td><td>Assemb</td><td>Disassemb</td></tr><tr><td>Empty</td><td>1.7 ± 0.8</td><td>42.1 ± 3.7</td><td>12.6 ± 1.4</td><td>1.7 ± 0.... |
efea6fe8d29b405b0d6d0a33d210d1dd535d91038895e2857a0f0213f8b7c246.png | complex | <table><tr><td>Contig</td><td>Accession number<sup>a</sup></td><td>Name and/or putative function</td><td>Organism</td><td><i>E</i> -value</td></tr><tr><td colspan="5">Cell wall degradation</td></tr><tr><td>Contig 27 – SS_024</td><td>SS1G_01493</td><td>β-xylosidase<sup>b</sup></td><td><i>S. sclerotiorum</i></... |
6e0698733ade05cb8229fb83045ce99cb0e82f9156f7b4c8d39f8ddeca2aec43.png | simple | <table><tr><td><i>Group</i></td><td><i>Test group</i></td><td><i>Control group</i></td><td><i>t</i></td><td><i>P</i></td></tr><tr><td>Duration of operation (min)</td><td>180.4±48.9</td><td>179.7±66.4</td><td>1.513</td><td>>0.05</td></tr><tr><td>Intraoperative bleeding volume (mL)</td><td>390.5±90.3</t... |
47a7dcb7e5c4d78057eafaa5c0d779e1fa993a66c38f19ca0c991991abcbde9d.png | simple | <table><tr><td>MBSR sessions completed</td><td>Number of participants</td><td>Percentage (%)</td></tr><tr><td>All</td><td>3</td><td>12%</td></tr><tr><td>7</td><td>8</td><td>32%</td></tr><tr><td>6</td><td>3</td><td>12%</td></tr><tr><td>5</td><td>1</td><td>4%</td></tr><tr><td>4</td><td>0</td><td>0%</td></tr><tr><td>3</td... |
06f87b4f06c8e1e8b34d28a403872e3af4d1bb2c0632950eb73adc6083395145.png | simple | <table><tr><td>Variable</td><td>Hazard ratio (95% CI)</td><td><i>P</i></td></tr><tr><td>Age: ≥50 versus <50</td><td>0.63 (0.08–5.19)</td><td>0.67</td></tr><tr><td>Age: ≥60 versus <60</td><td>0.55 (0.13–2.32)</td><td>0.42</td></tr><tr><td>Tumor size: >2 cm versus ≤2 cm<sup>a</sup><... |
895f69ac9bffb16acb6584d347c8c4b75ebc1d1efd157a0ebe060feea220bb3a.png | complex | <table><tr><td>Variable</td><td>1</td><td>2</td><td>3</td><td>4</td></tr><tr><td colspan="5">RIGHT/FRONTAL QUADRANT</td></tr><tr><td>1. Congruence effect</td><td></td><td></td><td></td><td></td></tr><tr><td>2. Association effect</td><td>0.055</td><td></td><td></td><td></td></tr><tr><td>3. Stroop interference</td><td>0.... |
73ea1245f83a44194112de7c192b51c5a48164487ff52fd73177d3873659afa6.png | simple | <table><tr><td><i>Species</i></td><td>Lot</td><td>Seeds/well</td><td>Linear regression</td><td>R<sup>2</sup></td></tr><tr><td><i>Phelipanche ramosa</i></td><td>St Martin de Fraigneau, France, 2005</td><td>120</td><td>A = 0.0023 gs + 0.011</td><td>0.976</td></tr><tr><td><i>Orobanche cumana</i></td><td>Longeville-sur-mer... |
203764a11f815b79d60ea79128dc30e289fc27ea87518ad8a6b48a9c30756c0c.png | complex | <table><tr><td></td><td colspan="4">1994–1999</td><td colspan="4">2000–2004</td><td colspan="4">2005–2009</td></tr><tr><td></td><td colspan="3">Empirical data</td><td>Spectrum estimate</td><td colspan="3">Empirical data</td><td>Spectrum estimate</td><td colspan="3">Empirical data</td><td>Spectrum esti... |
18c7ad7e6d55cfd122a6f99d7b904aacd3c0d45f1a9c8e2734fb1d23cae9499f.png | complex | <table><tr><td rowspan="2">Cutpoint</td><td rowspan="2">Method</td><td colspan="4">Level of burden</td></tr><tr><td>Heavy</td><td>Medium</td><td>Mild</td><td>None</td></tr><tr><td rowspan="3">0.9</td><td>PP</td><td>0.788</td><td>0.982</td><td>1.052</td><td>1.028</td></tr><tr><td>AT</td><td>0.749</td><td>0.983</td><td>1... |
52d7f0f762d875492512473fb65eb013508a2bc1b074538115303de39c9ff361.png | simple | <table><tr><td>Age of onset</td><td>Study population</td><td>Annual reported non-fatal early cases</td><td>Annual reported non-fatal late cases</td><td>Annual reported deaths</td><td>Annual YLLs with 0% under-reporting (age weighted)</td><td>Annual YLLs with 0% under-reporting (non-age weighted)</td><td>Annual deaths w... |
8d799da7d18e9e11ab993b7099cbbc6d914995fcca75df829d2a3bd5b0f36dc9.png | simple | <table><tr><td>Solvents</td><td>Possible replacement</td></tr><tr><td>benzonitrile</td><td>1,4-cineol</td></tr><tr><td>1-hexanol</td><td>N,N-diethylolcapramide</td></tr><tr><td>sulfolane</td><td>ethylene glycol</td></tr><tr><td>methyl tert-butyl ether</td><td>diethyl succinate</td></tr><tr><td>diethyl ether</td><td>eth... |
60e4d6d680062ac7c7d695c5adedf6b4692ca969bdbb4a41749e9c211a9da8f1.png | complex | <table><tr><td rowspan="2">Clinicopathologic Characteristic</td><td rowspan="2">Number</td><td colspan="2">Oct4</td><td rowspan="2">p value</td><td colspan="2">Sox2</td><td rowspan="2">p value</td></tr><tr><td>Negative N (%)</td><td>Positive N (%)</td><td>Negative N (%)</td><td>Positive N (%)</td></tr><tr><td>T stage</... |
21582be8be40f309110c8cba907d5fdfa5195fff468be000555f72de8d369e97.png | complex | <table><tr><td>Item</td><td>Criteria</td><td>Assessment</td></tr><tr><td rowspan="2">Validity</td><td>a) Are findings presented objectively?• Clear rationale and justification• Findings presented and discussed within appropriate context• Similar to existing literature and if not, reasons explainedR... |
b693f222569d87b3b4fdb94024faee280d147693c8bed634a4468fae2321884c.png | complex | <table><tr><td>Exposures</td><td>Low</td><td>High</td><td><i>P</i> for difference</td><td colspan="2">Odds ratios with 95% confidence interval for psychological impairment (High category is reference)</td></tr><tr><td colspan="5">MICRONUTRIENTS</td></tr><tr><td>Haemoglobin</td><td>28.7 (6.2)</td><td>28.5 (7.6)</td><td>... |
0fd82c7539a8e89cb8718bfad6df9de9d8b149e0bb44abaf13b73000a8981bd0.png | simple | <table><tr><td>Name</td><td>Sequence (5′→3′)</td><td>Position from ATG</td><td>Experimental use</td></tr><tr><td>ChsV-1</td><td>CAAGGACGAAAAGAGAGTAAC</td><td>+ 2769 (s)</td><td>RT-PCR</td></tr><tr><td>ChsV-3</td><td>TGTTGGTAGTTGTGATAATCGT</td><td>+ 2985 (as)</td><td>RT-PCR</td></tr><tr><td>B2m-F</td><... |
5d68143495a6c8f36fc532f52039eadaf1f947aa1224c2dc0b891325ef7cceb7.png | simple | <table><tr><td>Classification (α-angle)</td><td>Number (%)</td></tr><tr><td>Pathologic (>57°)</td><td>64 (14.6)</td></tr><tr><td>Borderline (51–56°)</td><td>66 (15.1)</td></tr><tr><td>Subtle (46–50°)</td><td>64 (14.6)</td></tr><tr><td>Very subtle (43–45°)</td><td>88 (20.1)<... |
90d86ab296580a02d9981d4269477e255c5c9e9300ae5a8fb8dea0530bbd5a6e.png | simple | <table><tr><td>Source</td><td>Age (months) sex</td><td>Time of sample colection</td><td>Symptoms<sup>a</sup>or signs</td><td>Clinical diagnosis</td><td>Comorbidity</td><td>Time in hospital (days)</td><td>Coinfecting viruses</td></tr><tr><td>infant</td><td>3/M</td><td>November 01, 2005</td><td>fever</td><td>bronchioliti... |
3d57463b181a01b1e22dd8320eae10d0cd8765c2a685d0bf866ae30d5aee0203.png | complex | <table><tr><td></td><td colspan="2">All women</td><td colspan="2">ZDV monotherapy</td><td colspan="2">Combination therapy</td></tr><tr><td><i>Parameter</i></td><td><i>2–6 months</i></td><td><i>6–12 months</i></td><td><i>2–6 months</i></td><td><i>Parameter</i></td><td><i>2–6 months</i></td><td><i... |
46c5645fdcaf121326f3d4361a9ab9a481ddfcd62263f151f2f3138670616b9f.png | complex | <table><tr><td rowspan="2">Region</td><td>Disposable Income</td><td>FAS Index</td><td>Std. Deviation</td><td>Family Car</td><td>Own Bedroom</td><td>No. of Computers</td><td>No. of Bathrooms</td><td>Dishwasher in Home</td><td>Family Holidays</td></tr><tr><td>(CZK/Year)</td><td>Mean (0–13)</td><td></td><td>Mean (0&... |
2b7394a37178525ab6026b229c682b59f29171e7291355e3f69f76a326a5cec2.png | simple | <table><tr><td>Source</td><td>No. of samples analyzed</td><td>No. of samples positive (%)</td></tr><tr><td>Well (n = 45)</td><td>241</td><td>72 (29.9)</td></tr><tr><td>Tap (n = 8)</td><td>56</td><td>4 (7.1)</td></tr><tr><td>Stream (n = 1)</td><td>21</td><td>11 (52.4)</td></tr><tr><td>Total</td><td>318</td><td>87 (27.4)... |
271d7385737b9dd178ee96ca92b836678a08ad8b749074c989c20635ac244574.png | simple | <table><tr><td>#</td><td>Name</td><td>Sequence</td></tr><tr><td>F1</td><td>SpeI-KDM4C-F1</td><td>GTACTAGTATGGAGGTGGCCGAGGTGGAA</td></tr><tr><td>R1</td><td>XhoI-KDM4C-R2121</td><td>ACTTGTTCCATCCTCCTCGAGGAAGGCATTGGGTGGAG</td></tr><tr><td>F2</td><td>Eco47III-D2A-F</td><td>GAGCCTCAGCGCTATGGCTTCTGAGTCTGAAACTCTGAAT</td></tr>... |
16cc6ced69e527afa58f14c89a29aa52e21005a78d4cbb703529409af2fc3251.png | complex | <table><tr><td> </td><td> </td><td> </td><td colspan="2">0–6 months</td><td colspan="2">>6 months</td></tr><tr><td>Baseline characteristics</td><td> </td><td>n<sup>1</sup></td><td>Crude HR(95% CI)</td><td>Adjusted<sup>2</sup> HR(95% CI)n = 10 283</td><td>Crude HR(95% CI)</td><td>Adjusted<sup>2</sup> HR(95% CI)... |
7281cbb3612cf8e39b598a33456d2e147d269d34e6dc3dd086013f046f777795.png | simple | <table><tr><td>Parameter</td><td>All Patients</td><td>ARMD Group</td><td>Non-ARMD Group</td><td>P Value: ARMD Versus Non-ARMD</td></tr><tr><td>Unilateral BHR</td><td></td><td></td><td></td><td></td></tr><tr><td> No. (%) of patients</td><td>323 (100)</td><td>38 (12)</td><td>285 (88)</td><td></td></tr><tr><td> Sex (F/M)<... |
eb40529099ce74d2163d8a37034039b3de3a50b160e8ddaff59cc299ac5219a0.png | complex | <table><tr><td rowspan="3">Leading health care problems (ICD code)</td><td colspan="2">Female</td><td colspan="2">Male</td></tr><tr><td>Moran’s I</td><td>p-value<sup>a</sup></td><td>Moran’s I</td><td>p-value<sup>a</sup></td></tr><tr><td>Infectious and parasitic diseases (ICD 01-07)</td><td>0.34</td><td>0.00... |
f92140c4ed50364922849fd41970e9c63767c1cbff82315b02a21af71347fadd.png | complex | <table><tr><td>Parameters</td><td>Coefficients</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td colspan="3">Effect of EQ-5D domains</td><td>Additional effect of patient groups</td><td>Additional effect of valuation own health</td></tr><tr><td></td><td>Cancer</td><td>RA</td><td>General population</td><td>Ca... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.